使用蛋白质组和遗传数据预测非向药物毒性:来自Torcetrapibib的见解
Jenifer A Brody1, Colleen M Sitlani1, Bruce M Psaty1,2
1Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.
medRxiv : the preprint server for health sciences
|December 17, 2025
概括
预测药物的不良影响至关重要. 这项研究引入了一个基因-蛋白质基因框架,使用门德尔的随机化来预测药物副作用,可能减少患者的伤害和药物开发成本.
科学领域:
- 药物基因组学 药物基因组学
- 药物开发 药物开发
- 生物标志物 生物标志物
背景情况:
- 晚期药物开发失败通常是由于不可预测的目标外不良副作用造成的.
- 临床试验中的蛋白质组变化和门德尔随机化提供了对药物对健康结果影响的见解.
- 旨在改变胆固醇的药物Torcetrapib意外增加了血压和死亡率.
研究的目的:
- 证明一个基因-蛋白质基因框架的原则证明,以预测药物不良影响.
- 利用孟德尔随机化来评估药物扰乱蛋白质对健康结果的因果影响.
- 通过改善对副作用的早期预测,减少对患者的伤害和药物开发成本.
主要方法:
- 采用孟德尔随机化来估计95种由torcetrapib改变的蛋白质的因果作用.
- 分析了ILLUMINATE试验的数据,该试验涉及3个月的托塞特拉皮布暴露.
- 评估了蛋白质变化对19个不同的健康结果的影响.
主要成果:
- 确定了六种蛋白质,其作用与观察到的试验结果一致.
- 观察到的C型曼诺酶受体2 (MRC2),PDE5A,SPON1和TIE1等蛋白质显示血压升高,反映了试验结果.
- 验证了遗传蛋白质组方法的预测能力.
结论:
- 开发的基因-蛋白质基因框架可用于预测潜在的不良药物影响.
- 这种方法可以显著减轻患者的风险,并降低药物失败的财务负担.
- 早期识别药物诱导的蛋白质变化可以指导更安全的药物开发策略.
更多相关视频
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
872
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
462
相关概念视频
01:29Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
163
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
163
01:16Therapeutic Drug Monitoring: Overview and Classification
270
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
270